NCT04538079

Brief Summary

Study type: Prospective Observational trial Study design: Longitudinal Population: Preterm newborns \<32 weeks gestational age Hypothesis: The inclusion of non-invasive physiological measures of cardiac output, peripheral perfusion and brain oxygenation (NIRS) for preterm neonates is feasible and reveals additional information on the hemodynamic status compared to blood pressure alone. These measurements can improve the ability to rapidly identify those infants who might benefit from intervention and are correlated with short term clinical outcomes.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
56

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2019

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 9, 2019

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

March 5, 2020

Completed
6 months until next milestone

First Posted

Study publicly available on registry

September 3, 2020

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2021

Completed
Last Updated

January 27, 2023

Status Verified

January 1, 2023

Enrollment Period

1.6 years

First QC Date

March 5, 2020

Last Update Submit

January 25, 2023

Conditions

Keywords

objective hemodynamic multimodal Monitoringpremature preterm infant

Outcome Measures

Primary Outcomes (1)

  • Adverse Outcome of Circulatory Failure

    Correlation of clinical, laboratory, conventional and multimodal non-invasive monitoring and/or a combination of variables with ultrasound abnormality (IVH grade 3 - 4/any IVH) or death within the first two weeks of life.

    14 days

Secondary Outcomes (14)

  • Feasibility of non-invasive Cardiac Output Monitoring and Pulsatility Index

    48 hours

  • Reproducibility of absolute left ventricular cardiac output estimated by echocardiography compared to cardiac output estimated by non-invasive Cardiac Output Monitoring

    48 hours

  • Reproducibility of left ventricular cardiac output indexed to bodyweight estimated by echocardiography compared to cardiac output estimated by non-invasive Cardiac Output Monitoring

    48 hours

  • Reproducibility of left ventricular stroke volume estimated by echocardiography compared to cardiac output estimated by non-invasive Cardiac Output Monitoring

    48 hours

  • Reproducibility of absolute right ventricular cardiac output indexed to bodyweight estimated by echocardiography compared to cardiac output estimated by non-invasive Cardiac Output Monitoring

    48 hours

  • +9 more secondary outcomes

Other Outcomes (6)

  • Burden of clinical suspicion indicating Circulatory Insufficiency

    48 hours

  • Burden of Laboratory parameters indicating Circulatory Insufficiency

    48 hours

  • Burden and Onset of Hypotension indicating Circulatory Insufficiency

    48 hours

  • +3 more other outcomes

Study Arms (2)

Feasibility/Accuracy/Reproducibility

The first 20 participants will be analysed for feasibility and the first 40 ECHOs for accuracy/reproducibility of non-invasive Cardiac Output Monitoring with ECHO as reference Method.

Device: Multimodal objective non-invasive Monitoring

Prediction of Circulatory Failure

Together with the Feasibility/Accuracy/Reproducibility Cohort this group's results will be analysed for prediction of circulatory failure defined as an ultrasound abnormality (IVH grade 3 - 4) or death within the first two weeks of life.

Device: Multimodal objective non-invasive Monitoring

Interventions

Multimodal objective non-invasive monitoring including cerebral oxygenation (NIRS), pulse oximetry with Pulsatility Index (PI) and non-invasive Cardiac Output Monitoring will be recorded but not used for clinical decision making. 2 ECHOs will be performed (one within the first 24h, one in the 2nd 24 hours after birth)

Feasibility/Accuracy/ReproducibilityPrediction of Circulatory Failure

Eligibility Criteria

Age1 Minute - 20 Hours
Sexall
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Preterm Neonates born at a gestational age of 23 weeks 0 days to 31 weeks 6 days.

You may qualify if:

  • Neonates of 23 weeks 0 days to 31 weeks 6 days
  • NIRS/non-invasive Cardiac Output - device available
  • Parental Informed Consent

You may not qualify if:

  • Congenital anomalies
  • Major cardiac defects
  • Hydrops
  • Parents decline to consent to the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Neonatal Unit Cork University Maternity Hospital

Cork, Ireland

Location

MeSH Terms

Conditions

HypotensionShock

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Eugene M Dempsey, MD

    UCC

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 5, 2020

First Posted

September 3, 2020

Study Start

November 9, 2019

Primary Completion

May 31, 2021

Study Completion

May 31, 2021

Last Updated

January 27, 2023

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will not share

Locations